
Stuart Therapeutics Phase II clinical trial results of its dry eye candidate
Stuart Therapeutics, a clinical stage, ophthalmic therapeutic development company, has announced the topline results of the first in human Phase II clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease. The trial The clinical trial, conducted between June and October… Read More















